Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis

Abstract Background The purpose of this study was to clarify the prognostic value of Pentraxin-3 (PTX3) on the mortality of patients with sepsis. Methods Publications published up to January 2021 were retrieved from PubMed, EMBASE, and the Cochrane library. Data from eligible cohort and case–control...

Full description

Bibliographic Details
Main Authors: Guobin Wang, Chunyan Jiang, Junjun Fang, Zhitao Li, Hongliu Cai
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Critical Care
Subjects:
Online Access:https://doi.org/10.1186/s13054-022-04032-x
_version_ 1818207759421669376
author Guobin Wang
Chunyan Jiang
Junjun Fang
Zhitao Li
Hongliu Cai
author_facet Guobin Wang
Chunyan Jiang
Junjun Fang
Zhitao Li
Hongliu Cai
author_sort Guobin Wang
collection DOAJ
description Abstract Background The purpose of this study was to clarify the prognostic value of Pentraxin-3 (PTX3) on the mortality of patients with sepsis. Methods Publications published up to January 2021 were retrieved from PubMed, EMBASE, and the Cochrane library. Data from eligible cohort and case–control studies were extracted for the meta-analysis. Multivariate regression analysis was used to evaluate the correlation of the outcomes with sample size and male proportion. Results A total of 17 studies covering 3658 sepsis patients were included. PTX3 level was significantly higher in non-survivor compared to survivor patients (SMD (95% CI): −1.06 (−1.43, −0.69), P < 0.001). Increased PTX3 level was significantly associated with mortality (HR (95% CI): 2.09 (1.55, 2.81), P < 0.001). PTX3 showed good predictive capability for mortality (AUC:ES (95% CI): 0.73 (0.70, 0.77), P < 0.001). The outcome comparing PTX3 level in non-survivors vs. survivors and the outcome of the association between PTX3 and mortality were associated with sample size but not male proportion. AUC was associated with both sample size and male proportion. Conclusions PTX3 level was significantly higher in non-survivor compared to survivor patients with sepsis. Elevated PTX3 level was significantly associated with mortality. Furthermore, the level of PTX3 might predict patient mortality.
first_indexed 2024-12-12T04:34:02Z
format Article
id doaj.art-be97aef9c49d4b4cbdfc22454dff8e7a
institution Directory Open Access Journal
issn 1364-8535
language English
last_indexed 2024-12-12T04:34:02Z
publishDate 2022-06-01
publisher BMC
record_format Article
series Critical Care
spelling doaj.art-be97aef9c49d4b4cbdfc22454dff8e7a2022-12-22T00:38:01ZengBMCCritical Care1364-85352022-06-0126111210.1186/s13054-022-04032-xPentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysisGuobin Wang0Chunyan Jiang1Junjun Fang2Zhitao Li3Hongliu Cai4Department of Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of MedicineAbstract Background The purpose of this study was to clarify the prognostic value of Pentraxin-3 (PTX3) on the mortality of patients with sepsis. Methods Publications published up to January 2021 were retrieved from PubMed, EMBASE, and the Cochrane library. Data from eligible cohort and case–control studies were extracted for the meta-analysis. Multivariate regression analysis was used to evaluate the correlation of the outcomes with sample size and male proportion. Results A total of 17 studies covering 3658 sepsis patients were included. PTX3 level was significantly higher in non-survivor compared to survivor patients (SMD (95% CI): −1.06 (−1.43, −0.69), P < 0.001). Increased PTX3 level was significantly associated with mortality (HR (95% CI): 2.09 (1.55, 2.81), P < 0.001). PTX3 showed good predictive capability for mortality (AUC:ES (95% CI): 0.73 (0.70, 0.77), P < 0.001). The outcome comparing PTX3 level in non-survivors vs. survivors and the outcome of the association between PTX3 and mortality were associated with sample size but not male proportion. AUC was associated with both sample size and male proportion. Conclusions PTX3 level was significantly higher in non-survivor compared to survivor patients with sepsis. Elevated PTX3 level was significantly associated with mortality. Furthermore, the level of PTX3 might predict patient mortality.https://doi.org/10.1186/s13054-022-04032-xPentraxin-3SepsisMortalityAUCMeta-analysis
spellingShingle Guobin Wang
Chunyan Jiang
Junjun Fang
Zhitao Li
Hongliu Cai
Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis
Critical Care
Pentraxin-3
Sepsis
Mortality
AUC
Meta-analysis
title Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis
title_full Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis
title_fullStr Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis
title_full_unstemmed Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis
title_short Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis
title_sort pentraxin 3 as a predictive marker of mortality in sepsis an updated systematic review and meta analysis
topic Pentraxin-3
Sepsis
Mortality
AUC
Meta-analysis
url https://doi.org/10.1186/s13054-022-04032-x
work_keys_str_mv AT guobinwang pentraxin3asapredictivemarkerofmortalityinsepsisanupdatedsystematicreviewandmetaanalysis
AT chunyanjiang pentraxin3asapredictivemarkerofmortalityinsepsisanupdatedsystematicreviewandmetaanalysis
AT junjunfang pentraxin3asapredictivemarkerofmortalityinsepsisanupdatedsystematicreviewandmetaanalysis
AT zhitaoli pentraxin3asapredictivemarkerofmortalityinsepsisanupdatedsystematicreviewandmetaanalysis
AT hongliucai pentraxin3asapredictivemarkerofmortalityinsepsisanupdatedsystematicreviewandmetaanalysis